Louis C. Bock, Director, 10% Owner at Orexigen Therapeutics, Inc. (OREX), sold 14,206 shares at $15.28 ($221K) on 2007-11-15, disclosed to the SEC on 2007-11-16.
Open-market sale of $221k OREX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.22 | 100 | $2K | 0.7% |
| 2 | $15.28 | 100 | $2K | 0.7% |
| 3 | $15.30 | 100 | $2K | 0.7% |
| 4 | $15.33 | 300 | $5K | 2.1% |
| 5 | $15.34 | 100 | $2K | 0.7% |
| 6 | $15.45 | 2,795 |
| $43K |
| 19.5% |
| 7 | $15.46 | 600 | $9K | 4.2% |
| 8 | $15.51 | 2,506 | $39K | 17.6% |
| 9 | $15.55 | 400 | $6K | 2.8% |
| 10 | $15.60 | 705 | $11K | 5.0% |
| 11 | $15.62 | 200 | $3K | 1.4% |
| 12 | $15.63 | 400 | $6K | 2.8% |
| 13 | $15.65 | 3,000 | $47K | 21.2% |
| 14 | $15.66 | 100 | $2K | 0.7% |
| 15 | $15.67 | 100 | $2K | 0.7% |
| 16 | $15.69 | 100 | $2K | 0.7% |
| 17 | $15.72 | 200 | $3K | 1.4% |
| 18 | $15.74 | 200 | $3K | 1.4% |
| 19 | $15.75 | 300 | $5K | 2.1% |
| 20 | $15.76 | 100 | $2K | 0.7% |
| 21 | $15.77 | 100 | $2K | 0.7% |
| 22 | $15.79 | 100 | $2K | 0.7% |
| 23 | $15.80 | 300 | $5K | 2.1% |
| 24 | $15.81 | 300 | $5K | 2.1% |
| 25 | $15.84 | 100 | $2K | 0.7% |
| 26 | $15.89 | 100 | $2K | 0.7% |
| 27 | $15.90 | 400 | $6K | 2.9% |
| 28 | $15.91 | 100 | $2K | 0.7% |
| 29 | $15.93 | 200 | $3K | 1.4% |
| 30 | $15.94 | 100 | $2K | 0.7% |
| Total | $15.59 avg | 14,206 | $221K | 100% |
| Filing → |
| OREX | BUY | 2014-11-13 | $151K | — | Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |